The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

Despite aggressive primary surgical cytoreduction and platinum-based chemotherapy, many women diagnosed with advanced epithelial ovarian cancer who achieve primary remission will experience disease ...

Feasibility and tolerability of multimodality treatment of locally advanced rectal cancer, particularly in elderly patients in a community cancer center. Background: Advance in chemotherapy for ...

A new guideline from ASCO updates evidence-based recommendations on the use of neoadjuvant chemotherapy and interval cytoreduction versus primary cytoreductive surgery (PCS) and chemotherapy in ...

It would not be an exaggeration to state that the goal of attempting to surgically maximally cytoreduce diffuse intraperitoneal ovarian cancer represents one of the most unique standard-of-care ...

Patients with advanced ovarian cancer who achieved complete cytoreduction had the best outcomes, regardless of the number of chemotherapy cycles before surgery. Increasing the number of chemotherapy ...

Ovarian cancer is the 5 th leading cancer killer amongst women, and mortality rates have remained largely unchanged over the past three decades. The current standard of care is cytoreductive surgery, ...

To the Editor: Vergote et al. (Sept. 2 issue) 1 report on two treatment strategies, but they also describe an alarming variability in the rate of optimal and complete cytoreduction. The range for ...

As ovarian cancer is usually diagnosed at an advanced stage, it is associated with a poor prognosis. The initial standard treatment is surgery, with the aim of debulking the primary carcinoma and ...